Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JAZZ
JAZZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JAZZ News
Zanidatamab Shows Breakthrough Efficacy in HER2-Positive Cancer Treatments
4d ago
PRnewswire
Zanidatamab Shows Breakthrough Efficacy in HER2-Positive Cancer
4d ago
Newsfilter
UBS Upgrades Jazz Pharmaceuticals to Buy, Highlights Ziihera's Potential
May 19 2026
seekingalpha
Latest Wall Street Ratings and Price Target Adjustments
May 19 2026
CNBC
Jazz Pharmaceuticals to Participate in Investor Conferences
May 12 2026
PRnewswire
Foreign Healthcare Stocks Show Strong Quant Ratings
May 07 2026
seekingalpha
Jazz Pharmaceuticals Reports Strong Q1 Performance
May 06 2026
Yahoo Finance
Jazz Pharmaceuticals Reports Record Q1 2026 Earnings with $1.1 Billion Revenue
May 06 2026
seekingalpha
U.S. Eases Restrictions on Cannabis Medicines, Unlocking Funding Potential
Apr 30 2026
Newsfilter
Jazz Pharmaceuticals' Ziihera Receives FDA Priority Review
Apr 27 2026
NASDAQ.COM
Jazz Pharmaceuticals' Ziihera Receives FDA Priority Review
Apr 27 2026
Newsfilter
Jazz Pharmaceuticals' Ziihera Receives FDA Priority Review
Apr 27 2026
PRnewswire
Jazz Pharmaceuticals to Report Q1 2026 Financial Results on May 5
Apr 21 2026
PRnewswire
Jazz Pharmaceuticals Presents Research at AAN Annual Meeting on Rare Neurological Disorders
Apr 09 2026
PRnewswire
PHARMA MAR - ROCHE AND JAZZ PHARMACEUTICALS COLLABORATE ON PHASE 3 IMFORTE TRIAL
Mar 27 2026
moomoo
American Nutrition Association Partners with Jazz Pharmaceuticals to Promote Low Sodium Diets
Mar 24 2026
Newsfilter
Show More News
